Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer

Clinical trial NCT00820898 · COMPLETED

Trial details

NCT number: NCT00820898
Sponsor: Gynecologic Oncology Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Endometrial Adenocarcinoma Endometrial Adenosquamous Carcinoma Endometrial Clear Cell Adenocarcinoma Recurrent Uterine Corpus Carcinoma

Start date: 2009-02-01
Primary completion: 2011-01-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.